TITLE

Stem Cells as Promising Future Tissue Filler

AUTHOR(S)
Attala, Mark
PUB. DATE
August 2011
SOURCE
Plastic Surgery Practice;Aug2011, Vol. 21 Issue 8, p24
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on the regenerative applications of stem cells as a tissue filler. It says that embryonic stem cells have an in vitro capacity forming cardiomyocytes when cultured while adipose tissue-derived stem cells able to differentiate into cartilage and adipose tissue. It mentions that adult human stem cells are used for autologous fat grafting. Moreover, the study by Yoshimura and colleagues cites the use of stem-cell-supplemented fat transplantation for soft-tissue fill.
ACCESSION #
63282989

 

Related Articles

  • A Comparison of Stem Cells for Therapeutic Use. Rodgerson, Denis; Harris, Alan // Stem Cell Reviews & Reports;Dec2011, Vol. 7 Issue 4, p782 

    A critical comparison of the attributes of several types of stem cells is presented, with particular emphasis on properties that are critical for the application of these cells for therapeutic purposes. The importance of an autologous source of pluripotent stem cells is stressed. It is apparent...

  • Therapeutic potential of stem cells in veterinary practice. Gade, Nitin E.; Pratheesh, M. D.; Nath, Amar; Dubey, Pawan K.; Amarpal; Sharma, G. Taru // Veterinary World;Aug2012, Vol. 5 Issue 8, p499 

    Stem cell research acquired great attention during last decade inspite of incredible therapeutic potential of these cells the ethical controversies exists. Stem cells have enormous uses in animal cloning, drug discovery, gene targeting, transgenic production and regenerative therapy. Stem cells...

  • Stemming Our Irrational Exuberance. Brenner, Malcolm K. // Molecular Therapy;Aug2011, Vol. 19 Issue 8, p1399 

    The author reflects on the technique to generate human embryonic stem cells (hESCs) and inducible pluripotent stem cells (iPSCs). He says that hESCs and iPSCs are genetically modified and has a major benefit for almost every disease. An overview of the argument regarding the bond issue for the...

  • Senescence suppressors: their practical importance in replicative lifespan extension in stem cells. Hwang, Eun // Cellular & Molecular Life Sciences;Nov2014, Vol. 71 Issue 21, p4207 

    Recent animal and clinical studies report promising results for the therapeutic utilization of stem cells in regenerative medicine. Mesenchymal stem cells (MSCs), with their pluripotent nature, have advantages over embryonic stem cells in terms of their availability and feasibility. However,...

  • Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. Narsinh, Kazim H.; Sun, Ning; Sanchez-Freire, Veronica; Lee, Andrew S.; Almeida, Patricia; Shijun Hu; Jan, Taha; Wilson, Kitchener D.; Leong, Denise; Rosenberg, Jarrett; Yao, Mylene; Robbins, Robert C.; Wu, Joseph C.; Hu, Shijun // Journal of Clinical Investigation;Mar2011, Vol. 121 Issue 3, p1217 

    Human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs) are promising candidate cell sources for regenerative medicine. However, despite the common ability of hiPSCs and hESCs to differentiate into all 3 germ layers, their functional equivalence at the single cell...

  • Personalized Regenerative Medicine. Arjmand, Babak; Goodarzi, Parisa; Mohamadi-Jahani, Fereshteh; Falahzadeh, Khadijeh; Larijani, Bagher // Acta Medica Iranica;2017, Vol. 55 Issue 3, p144 

    Personalized medicine as a novel field of medicine refers to the prescription of specific therapeutics procedure for an individual. This approach has established based on pharmacogenetic and pharmacogenomic information and data. The terms precision and personalized medicines are sometimes...

  • The persistence of memory.  // Nature Medicine;Oct2010, Vol. 16 Issue 10, p1082 

    The article presents insights from Alan Trounson, Martin Pera, and Shinya Yamanaka on the use of induced pluripotent stem cells (iPSCs) that carry epigenetic memory in therapy and drug development. Trounson states that the epigenetic memory carried by iPSCs must be studied to prevent phenotypic...

  • Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies. Ratcliffe, Elizabeth; Glen, Katie E.; Naing, May Win; Williams, David J. // British Medical Bulletin;Dec2013, Vol. 108 Issue 1, p73 

    Background Apart from haematopoietic stem cell transplantation for haematological disorders many stem cell-based therapies are experimental. However, with only 12 years between human embryonic stem cell isolation and the first clinical trial, development of stem cell products for regenerative...

  • Keeping an eye on stem cells for studying disease modelling and cell-based therapy. Crombie, Duncan // Australasian Biotechnology;Mar2013, Vol. 23 Issue 1, p19 

    The article discusses the use of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) in treating eye-related diseases. Topics featured in the discussion include regenerative medicine, cell differentiation, and stem cell-based therapy. It mentions the Centre for Eye Research...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics